TELECONFERENCE

High Alert Medication Series Part III
Reducing the Risk of Patient Harm from Chemotherapeutic Agents

Registration for the teleconference has expired.

PROGRAM OVERVIEW Cancer chemotherapy poses a unique set of risks to patients, particularly due to the complexity of therapeutic regimes, the variability in dosing, and the toxic nature of the drugs involved. Join us for part three of ISMP’s four-part high-alert teleconference series, Reducing the Risk of Patient Harm from Chemotherapeutic Agents on July 23, 2009 from 1:30 pm to 3:00 pm ET. Learn from the experts why errors associated with chemotherapy are so problematic and how to apply high-leverage error-reduction strategies in your organization to mitigate risk and prevent harm. The following topics will be discussed: • Patient assessment and prescribing of chemotherapeutic agents • Monitoring of therapy • Dosing errors • Errors due to labeling and packaging • Errors due to look- and sound-alike drug names • Drug storage issues • Safety practices associated with chemotherapy administration • Measures to evaluate the safe use of chemotherapeutic agents

INTENDED AUDIENCE (Interdisciplinary teams are encouraged to attend together):

• Physicians, primarily oncologists
• Nurses, especially those working in inpatient and outpatient oncology settings
• Pharmacists
• Risk and Quality Managers
• Medication Safety and Patient Safety Officers

OBJECTIVES

Following completion of this teleconference, participants should be able to:

• Describe preventable adverse events with chemotherapy and their causes
• Identify best practices that can improve safety when prescribing, dispensing, and administering chemotherapy
• Discuss the role of the practitioner in monitoring and managing the care of patients who are receiving chemotherapy
• Construct two measures that can be used to assess the safe use of chemotherapeutic agents

MODERATOR

• Ann Shastay, RN, MSN, AOCN, Managing Editor, Institute for Safe Medication Practices, Horsham, PA

SPEAKERS

• Sylvia Bartel, RPh, MPH, Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA

PRICING INFORMATION

Live Teleconference	$215.00
Live Teleconference and Teleconference CD	$245.00 (Plus $5.00 S&H)
Teleconference CD	$215.00 (Plus $5.00 S&H)
*CD includes a file of the audio recording of the teleconference as well as PowerPoint files containing slides of each presentation.

TELECONFERENCE POLICIES

Registration

• One telephone line connection is allowed per registration. Others may listen on this telephone line via an internal extension, or a speakerphone may be used for larger groups.
• You may not set up conferencing capabilities for other sites outside the facility. Each specific site may be used for larger groups. Each specific site must register individually.
• We cannot accept registrations without an email address and the name of a contact person.
• Registration for this teleconference will end at midnight ET on 7/22/2009.
• CDs will be available for purchase after the teleconference.

Cancellations

• Cancellations must be requested via an email message to our teleconference department.
• Cancellations received before the start (1:30 pm ET) of the teleconference will receive a full refund or credit.
• Cancellations received after the start (1:30 pm ET) of the teleconference and within 3 business days after the teleconference will be assessed a cancellation fee of $50.00.
• If your organization does not cancel within 3 business days after the date of the teleconference and does not participate, the full registration fee will be charged.

Materials

• If your organization's registered participant does not receive the teleconference materials that are sent out approximately 2 days before the teleconference via email, please send an email message to our billing department prior to the start of the teleconference.
  
• When registering, please be sure to provide the email address of the person to whom ISMP should send these materials.

---

Accreditation Information:

NOTE: There is no additional charge for continuing education credits for this teleconference.

Pharmacy Continuing Education Continuing education credits will be provided by The Pediatric Pharmacy Advocacy Group. PPAG is an approved provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education (ACPE). This program has been approved for 1.5 contact hours (0.15 CEUs). The UPN is: 180-999-09-526-L04-P. Nursing Continuing Education Debora Simmons is approved by the California Board of Nurse Examiners as a provider of continuing nursing education. This program has been assigned the Universal Program Number CEP 13677 and is approved for 1 contact hours (0.1 CEUs) of continuing nursing education.